Maitra Sanjay, Sekercioglu Nigar, Baloch Saaed, Cook Wendy L, Jassal Sarbjit V
University of Health Network, 200 Elizabeth St, Room 8N-857, M5G 2C4 Toronto, ON, Canada.
Int Urol Nephrol. 2007;39(1):345-50. doi: 10.1007/s11255-006-9032-6. Epub 2007 Mar 1.
Despite significant improvements in renal management the mortality associated with dialysis care remains high. Many renal registries report mortality statistics on an annual basis. The objectives of this study were (1) to establish the accuracy of the registered cause of death (CoD) against that determined by a panel of physicians; and (2) to test the feasibility of using the HEMO study CoD classification system in patients on peritoneal dialysis (PD).
Single centre tertiary-care hospital.
Patients were selected from those aged > or = 65 years who died while receiving PD. The CoD was identified from that registered with the local renal registry, and from clinical records.
(1) Sensitivity, specificity, positive predictive values (PPV), negative predictive values (NPV) and kappa score comparing registered and extracted CoD. (2) The proportions of deaths in seven categories using two classification systems.
A total of 51 patient charts were reviewed. The agreement between the registered and extracted CoD was poor for all causes of death except malignancy. Kappa scores ranged from 0.55 to 1.0 for different causes. PPV were poor for all except malignancy. Comparison of the CoD was highly dependent on the classification method used (e.g., death secondary to infection was 4% and 25% for CORR and HEMO, respectively).
The registered CoD for patients who die while on PD is often inaccurate. Different policies for classifying deaths can have a significant effect on the final reports, which show the proportion of deaths attributed to different diseases. Standardization across registries is required.
尽管在肾脏管理方面有显著改善,但与透析护理相关的死亡率仍然很高。许多肾脏登记处每年都会报告死亡率统计数据。本研究的目的是:(1)确定登记的死亡原因(CoD)与一组医生确定的死亡原因相比的准确性;(2)测试在腹膜透析(PD)患者中使用血液透析(HEMO)研究CoD分类系统的可行性。
单中心三级护理医院。
从年龄≥65岁且在接受PD治疗期间死亡的患者中进行选择。从当地肾脏登记处登记的信息以及临床记录中确定CoD。
(1)比较登记的和提取的CoD的敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和kappa评分。(2)使用两种分类系统时七类死亡情况的比例。
共审查了51份患者病历。除恶性肿瘤外,登记的和提取的CoD在所有死亡原因上的一致性都很差。不同原因的kappa评分范围为0.55至1.0。除恶性肿瘤外,所有原因的PPV都很差。CoD的比较高度依赖于所使用的分类方法(例如,感染继发死亡在CORR和HEMO分类中分别为4%和25%)。
接受PD治疗期间死亡患者的登记CoD往往不准确。不同的死亡分类政策可能会对最终报告产生重大影响,最终报告显示了归因于不同疾病的死亡比例。各登记处需要进行标准化。